Peter Höglund (Former)
101 – 110 of 202
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article
-
Mark
Errors in medication history at hospital admission : Prevalence and predicting factors
(
- Contribution to journal › Article
-
Mark
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
(
- Contribution to journal › Article
- 2011
-
Mark
Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits.
(
- Contribution to journal › Article
-
Mark
Long-term patient survival in ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
The process of identifying, solving and preventing drug related problems in the LIMM-study
(
- Contribution to journal › Article
-
Mark
The prognostic value of BVAS and VDI in ANCA-AAV
2011) 15th International Vasculitis/ANCA Workshop In Clinical and Experimental Immunology 164(Suppl. 1). p.121-121(
- Contribution to journal › Published meeting abstract
-
Mark
A Model to Predict Cardiovascular Events in Patients With Newly Diagnosed Wegener's Granulomatosis and Microscopic Polyangiitis
(
- Contribution to journal › Article
-
Mark
High dose methotrexate treatment in children with acute lymphoblastic leukaemia may be optimised by a weight-based dose calculation.
(
- Contribution to journal › Article
-
Mark
Validation of a modified EuroSCORE risk stratification model for cardiac surgery: the Swedish experience.
(
- Contribution to journal › Article